Li Z - Search Results

1

Effect of prior lenalidomide or daratumumab exposure on hematopoietic stem cell collection and reconstitution in multiple myeloma.

Duan H, Jiang Q, Liu L, Deng M, Lai Q, Jiang Y, Li Z, Xu B, Lin Z. Duan H, et al. Among authors: li z. Ann Hematol. 2024 Oct;103(10):3839-3853. doi: 10.1007/s00277-024-05683-2. Epub 2024 Mar 6. Ann Hematol. 2024. PMID: 38448787 Review.

2

PD-1 Antibody Monotherapy for Malignant Melanoma: A Systematic Review and Meta-Analysis.

Lin Z, Chen X, Li Z, Luo Y, Fang Z, Xu B, Han M. Lin Z, et al. Among authors: li z. PLoS One. 2016 Aug 2;11(8):e0160485. doi: 10.1371/journal.pone.0160485. eCollection 2016. PLoS One. 2016. PMID: 27483468 Free PMC article. Review.

3

Prognostic role of TET2 deficiency in myelodysplastic syndromes: A meta-analysis.

Lin Y, Lin Z, Cheng K, Fang Z, Li Z, Luo Y, Xu B. Lin Y, et al. Among authors: li z. Oncotarget. 2017 Jun 27;8(26):43295-43305. doi: 10.18632/oncotarget.17177. Oncotarget. 2017. PMID: 28476038 Free PMC article.

4

CD4+ T cell-mediated cytotoxicity is associated with MHC class II expression on malignant CD19+ B cells in diffuse large B cell lymphoma.

Zhou Y, Zha J, Lin Z, Fang Z, Zeng H, Zhao J, Luo Y, Li Z, Xu B. Zhou Y, et al. Among authors: li z. Exp Cell Res. 2018 Jan 15;362(2):287-292. doi: 10.1016/j.yexcr.2017.11.029. Epub 2017 Nov 22. Exp Cell Res. 2018. PMID: 29174982

5

The prognostic impact of long noncoding RNA HOTAIR in leukemia and lymphoma: a meta-analysis.

Lin Y, Fang Z, Lin Z, Li Z, Zhao J, Luo Y, Xu B. Lin Y, et al. Among authors: li z. Hematology. 2018 Oct;23(9):600-607. doi: 10.1080/10245332.2018.1446572. Epub 2018 Mar 7. Hematology. 2018. PMID: 29513085 Free article. Review.

6

The role of bortezomib in newly diagnosed diffuse large B cell lymphoma: a meta-analysis.

Lin Z, Chen X, Li Z, Zhou Y, Fang Z, Luo Y, Zhao J, Xu B. Lin Z, et al. Among authors: li z. Ann Hematol. 2018 Nov;97(11):2137-2144. doi: 10.1007/s00277-018-3435-1. Epub 2018 Jul 19. Ann Hematol. 2018. PMID: 30027435 Review.

7

Impairment of Vα24-Jα18⁺Vβ11⁺ natural killer T cells in adult acute lymphoblastic leukemia patients.

Zhao H, Li Z, Xie S, Luo Y, Zhou Y, Deng M, Zeng H, Zhao J, Yu L, Xu B. Zhao H, et al. Among authors: li z. Exp Cell Res. 2019 Jan 1;374(1):69-75. doi: 10.1016/j.yexcr.2018.11.008. Epub 2018 Nov 12. Exp Cell Res. 2019. PMID: 30439366

8

IL-21-mediated expansion of Vγ9Vδ2 T cells is limited by the Tim-3 pathway.

Wu K, Zhao H, Xiu Y, Li Z, Zhao J, Xie S, Zeng H, Zhang H, Yu L, Xu B. Wu K, et al. Among authors: li z. Int Immunopharmacol. 2019 Apr;69:136-142. doi: 10.1016/j.intimp.2019.01.027. Epub 2019 Jan 29. Int Immunopharmacol. 2019. PMID: 30708194

9

Napabucasin (BBI608) eliminate AML cells in vitro and in vivo via inhibition of Stat3 pathway and induction of DNA damage.

Bi S, Chen K, Feng L, Fu G, Yang Q, Deng M, Zhao H, Li Z, Yu L, Fang Z, Xu B. Bi S, et al. Among authors: li z. Eur J Pharmacol. 2019 Jul 15;855:252-261. doi: 10.1016/j.ejphar.2019.05.020. Epub 2019 May 11. Eur J Pharmacol. 2019. PMID: 31085238

10

Vδ2 T cell subsets, defined by PD-1 and TIM-3 expression, present varied cytokine responses in acute myeloid leukemia patients.

Wu K, Feng J, Xiu Y, Li Z, Lin Z, Zhao H, Zeng H, Xia W, Yu L, Xu B. Wu K, et al. Among authors: li z. Int Immunopharmacol. 2020 Mar;80:106122. doi: 10.1016/j.intimp.2019.106122. Epub 2020 Jan 16. Int Immunopharmacol. 2020. PMID: 31955066

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113,415 results

Search Page

Filters